ENDOU
Uridylate-specific endoribonuclease
Also known as: ENDOU_HUMAN, P11, PP11, PRSS26
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P21128
- Gene
- ENDOU
- Ensembl
- ENSG00000111405
- Chromosome
- 12
- Canonical length
- 410 aa
- Protein class
- Predicted secreted proteins
- Secretome location
- Secreted in other tissues
OverviewNCBI Gene
This gene encodes a protein with endoribonuclease activity that binds polyuridine-enriched single-stranded RNA. This gene was initially characterized based on its high expression in placenta but was mischaracterized as a serine protease. In mouse, this gene promotes tolerance to self-antigens by regulating B cell activation-induced cell death (AICD). The protein may be useful as a tumor marker. Multiple alternatively spliced transcript variants encoding distinct protein isoforms have been found for this gene. [provided by RefSeq, Jul 2020]
Canonical amino-acid sequenceUniProt
410 residues, UniProt reviewed canonical sequence.
>P21128|ENDOU
1 MRACISLVLA VLCGLAWAGK IESCASRCNE KFNRDAACQC DRRCLWHGNC CEDYEHLCTE
61 DHKESEPLPQ LEEETEEALA SNLYSAPTSC QGRCYEAFDK HHQCHCNARC QEFGNCCKDF
121 ESLCSDHEVS HSSDAITKEE IQSISEKIYR ADTNKAQKED IVLNSQNCIS PSETRNQVDR
181 CPKPLFTYVN EKLFSKPTYA AFINLLNNYQ RATGHGEHFS AQELAEQDAF LREIMKTAVM
241 KELYSFLHHQ NRYGSEQEFV DDLKNMWFGL YSRGNEEGDS SGFEHVFSGE VKKGKVTGFH
301 NWIRFYLEEK EGLVDYYSHI YDGPWDSYPD VLAMQFNWDG YYKEVGSAFI GSSPEFEFAL
361 YSLCFIARPG KVCQLSLGGY PLAVRTYTWD KSTYGNGKKY IATAYIVSSTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ENDOU can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.32
- Highest tissue expression
- 81 nTPM
Expression across tissuesHPA
Tissue
- esophagus: 81 nTPM
- vagina: 30 nTPM
- cervix: 23 nTPM
- salivary gland: 20 nTPM
- skin: 20 nTPM
- tonsil: 8.2 nTPM
Single-cell type
- esophageal apical cells: 512 nCPM
- esophageal suprabasal cells: 123 nCPM
- suprabasal keratinocytes: 88 nCPM
- syncytiotrophoblasts: 75 nCPM
- endometrial glandular cells: 18 nCPM
- endometrial luminal cells: 12 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- hippocampal formation: 3.2 nTPM
- basal ganglia: 3.1 nTPM
- pons: 3 nTPM
- thalamus: 3 nTPM
- cerebellum: 2.8 nTPM
- midbrain: 2.6 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.3
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.65
- DepMap mean gene effect
- -0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- female pregnancy
- immune response
- negative regulation of lipid catabolic process
- post-transcriptional gene silencing
- proteolysis
Molecular functions
- growth factor activity
- lyase activity
- manganese ion binding
- polysaccharide binding
- RNA binding
- RNA endonuclease activity
- scavenger receptor activity
- serine-type peptidase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Somatomedin B domain
- Somatomedin B domain, chordata
- Somatomedin B-like domain superfamily
- Somatomedin B domain
- EndoU ribonuclease, C-terminal
- Endoribonuclease EndoU-like
- Poly(U)-specific endoribonuclease
- Endoribonuclease XendoU
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ENDOU as an antibody target. Whether an autoantibody or antibody against ENDOU could matter depends on whether native ENDOU is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ENDOU is annotated as secreted, so native ENDOU circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label ENDOU as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...